Schouw & Co. share buy-back programme, week 10 2026
On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount DKK | ||
| Accumulated until 27 February 2026 | 81,283 | 678.18 | 55,124,691 | ||
| Monday, 2 March 2026 | 1,000 | 670.00 | 670,000 | ||
| Tuesday, 3 March 2026 | 1,000 | 651.00 | 651,000 | ||
| Wednesday, 4 March 2026 | 1,000 | 647.00 | 647,000 | ||
| Thursday, 5 March 2026 | 1,000 | 615.00 | 615,000 | ||
| Friday, 6 March 2026 | 1,000 | 639.00 | 639,000 | ||
| In the period 2 March 2026 - 6 March 2026 | 5,000 | 644.40 | 3,222,000 | ||
| Accumulated until 6 March 2026 | 86,283 | 676.22 | 58,346,691 | ||
| Following the above transactions, Schouw & Co. holds a total of 2,329,076 treasury shares corresponding to 9.32% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cloudastructure Appoints Nile Coates as Chief Revenue Officer to Accelerate Commercial Growth Across Enterprise Markets
- 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
- Intersignal Demonstrates Cross-Model Semantic State Transfer Between Local AI Systems
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share